Patient tolerated oral ingestion. CRP levels were 1.2 mg/L. It was decided to discharge the patient and manage him as an outpatient. 2 mg/kg of azathioprine were added to his medication for combination therapy, with scheduled IFX doses at 2 and 6 weeks following first infusion. Instructions were given to gradually reduce prednisone. Outpatient management of inflammatory bowel disease has continued.
Al décimo día el paciente presenta 2 deposiciones diarias, sin sangrado, sin artralgias y disminución de lesiones de eritema nodoso, tolerando vía oral y con niveles de PCR 1,2 mg/L, se decide manejo ambulatorio, se adiciona azatioprina 2 mg/kg como terapia combinada, se programa para nueva dosis de IFX en 2 y 6 semanas posterior a la primera infusión, se dan instrucciones de disminución gradual de prednisona y se continúa manejo por consulta externa de enfermedad inflamatoria intestinal.